Regulation of apoA-I gene expression: mechanism of action of estrogen and genistein.
about
Association of polymorphisms in genes involved in lipoprotein metabolism with plasma concentrations of remnant lipoproteins and HDL subpopulations before and after hormone therapy in postmenopausal women.Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal womenTamoxifen alters the plasma concentration of molecules associated with cardiovascular risk in women with breast cancer undergoing chemotherapyPhytoestrogens regulate mRNA and protein levels of guanine nucleotide-binding protein, beta-1 subunit (GNB1) in MCF-7 cellsChanges in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women.Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.Serum 2-methoxyestradiol, an estrogen metabolite, is positively associated with serum HDL-C in a population-based sample.The effect of nutritional supplements on serum high-density lipoprotein cholesterol and apolipoprotein A-I.Oestrogen receptor alpha is required for biochanin A-induced apolipoprotein A-1 mRNA expression in HepG2 cells.The impact of gender and serum estradiol levels on HDL-mediated reverse cholesterol transport.Cocoa flavanol metabolites activate HNF-3β, Sp1, and NFY-mediated transcription of apolipoprotein AI in human cells.Alpinumisoflavone and abyssinone V 4'-methylether derived from Erythrina lysistemon (Fabaceae) promote HDL-cholesterol synthesis and prevent cholesterol gallstone formation in ovariectomized rats.Genistein and daidzein induced apoA-1 transactivation in hepG2 cells expressing oestrogen receptor-alpha.Insight into molecular pathways of retinal metabolism, associated with vitellogenesis in zebrafish.
P2860
Q33835305-EB5E59E6-60C2-41FB-816C-D6DF68DA0151Q35590308-C5F2F6E7-ECD1-4828-AB4F-7E769F63A026Q35913219-C826AB2A-BEF4-4F1E-99DA-A3278B6A5B50Q35990686-7AE4F51D-BF92-469B-A68B-F04F75A04D4DQ37237180-FEA97244-CB4B-4544-900B-F2520DFD6EA3Q37386911-4B24A245-B5EF-42B5-A57B-5179981B6E9BQ37442901-3E1FF0CE-AFD2-4125-9CEC-2E0D684E19B8Q38194113-2E0864B3-1595-430F-A8AF-74101F7AE06CQ40127068-C7718AD0-2A34-4823-9270-A2D050DB2901Q43808424-5F2545A2-27FC-4847-9E55-9ED71AA6573EQ45388143-039522A7-F714-495B-BAD4-4C7ED4976CACQ46405344-9E9210D8-5BA3-424F-88B3-AA89722D83A7Q46898500-9C512DE2-1C52-44F7-A428-6755B88781DBQ48658406-AB86AFB5-6E4C-46FD-A319-931781441EEB
P2860
Regulation of apoA-I gene expression: mechanism of action of estrogen and genistein.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Regulation of apoA-I gene expression: mechanism of action of estrogen and genistein.
@en
type
label
Regulation of apoA-I gene expression: mechanism of action of estrogen and genistein.
@en
prefLabel
Regulation of apoA-I gene expression: mechanism of action of estrogen and genistein.
@en
P2860
P1476
Regulation of apoA-I gene expression: mechanism of action of estrogen and genistein.
@en
P2093
Dale Micherone
Stefania Lamon-Fava
P2860
P304
P356
10.1194/JLR.M300179-JLR200
P577
2003-10-16T00:00:00Z